Ligand validation:2ESD

NAP: NADP NICOTINAMIDE-ADENINE-DINUCLEOTIDE PHOSPHATE

NAP is a Ligand Of Interest in 2ESD designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
2ESD_NAP_C_3476	20%	16%	0.192	0.791	2.14	1.6	11	14	2	0	100%	0.5
2ESD_NAP_D_4476	13%	15%	0.188	0.732	2.2	1.57	12	13	0	0	100%	0.5
2ESD_NAP_A_1476	10%	14%	0.181	0.684	2.26	1.62	13	13	2	0	100%	0.5
2ESD_NAP_B_2476	8%	15%	0.207	0.674	2.2	1.61	12	13	0	0	100%	0.5
2ID2_NAP_C_3003	73%	17%	0.13	0.956	2.07	1.52	12	10	4	0	100%	0.8
2QE0_NAP_C_3476	47%	7%	0.175	0.915	2.24	2.5	14	26	8	0	100%	0.71
2DBQ_NAP_A_401	100%	24%	0.017	0.998	1.42	1.71	7	16	0	0	100%	1
2EXX_NAP_A_3698	100%	10%	0.025	0.996	1.63	2.7	7	18	9	0	100%	1
6IJX_NAP_A_401	100%	59%	0.014	0.998	0.63	0.95	1	3	4	0	100%	1
9FOB_NAP_A_401	100%	56%	0.023	0.996	0.78	0.91	2	3	1	0	100%	1
9OOI_NAP_B_301	100%	29%	0.025	0.997	1.81	1.07	5	4	6	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.